Gene expression profiling in the synovium identifies a predictive signature of absence of response to adalimumab therapy in rheumatoid arthritis
about
A systems biology approach to synovial joint lubrication in health, injury, and diseaseGene expression analysis in RA: towards personalized medicineThe gene expression profile in the synovium as a predictor of the clinical response to infliximab treatment in rheumatoid arthritisEvaluation of arthroscopy and macroscopic scoring.Can Synovial Pathobiology Integrate with Current Clinical and Imaging Prediction Models to Achieve Personalized Health Care in Rheumatoid Arthritis?Synovial phenotypes in rheumatoid arthritis correlate with response to biologic therapeutics.Validation study of existing gene expression signatures for anti-TNF treatment in patients with rheumatoid arthritisCirculating cytokine profiles and their relationships with autoantibodies, acute phase reactants, and disease activity in patients with rheumatoid arthritis.NF-AT5 is a critical regulator of inflammatory arthritisCD4 T-cell transcriptome analysis reveals aberrant regulation of STAT3 and Wnt signaling pathways in rheumatoid arthritis: evidence from a case-control study.Heterogeneity of synovial molecular patterns in patients with arthritis.A personalized medicine approach to biologic treatment of rheumatoid arthritis: a preliminary treatment algorithm.Is there a role of synovial biopsy in drug development?Killer immunoglobulin-like receptor and human leukocyte antigen-C genotypes in rheumatoid arthritis primary responders and non-responders to anti-TNF-α therapy.Screening for peptides targeted to IL-7Rα for molecular imaging of rheumatoid arthritis synoviumThe genetics of human autoimmune disease: A perspective on progress in the field and future directions.Higher expression of TNFα-induced genes in the synovium of patients with early rheumatoid arthritis correlates with disease activity, and predicts absence of response to first line therapy.Correlation of Serum Soluble Interleukin-7 Receptor and Anti-C1q Antibody in Patients with Systemic Lupus Erythematosus.Rheumatoid arthritis synovial fibroblasts produce a soluble form of the interleukin-7 receptor in response to pro-inflammatory cytokines.Recent advances in neutralizing the IL-6 pathway in arthritis.Immune and inflammatory gene expressions are different in Behçet's disease compared to those in Familial Mediterranean Fever.The potential use of expression profiling: implications for predicting treatment response in rheumatoid arthritis.Rituximab treatment induces the expression of genes involved in healing processes in the rheumatoid arthritis synovium.Affibody molecules as engineered protein drugs.Synovial tissue research: a state-of-the-art review.[Fifteen years of the histopathological synovitis score : Review and further developments of a diagnostic score].Right drug, right patient, right time: aspiration or future promise for biologics in rheumatoid arthritis?Global molecular effects of tocilizumab therapy in rheumatoid arthritis synovium.sIL7R concentrations in the serum reflect disease activity in the lupus kidney.Analysis of SF and plasma cytokines provides insights into the mechanisms of inflammatory arthritis and may predict response to therapy.Pharmacogenomics in rheumatoid arthritis: how close are we to the clinic?
P2860
Q24608533-BB150827-DA74-4999-9BB5-F2E58F5C585BQ26825706-704D5B7F-BA0A-4BEA-B960-2A1DB3948C12Q28751012-E6CAB346-F1AD-41F7-895E-8DF50F5777BAQ30488975-C1C068FB-6313-436D-BFEB-4C336E91B735Q33627758-D3496BAE-8DA2-4E13-814A-4F2C93C14F1AQ33766404-5436744E-6C13-4A0D-A6F7-5D74301A2ECEQ34211769-00288A98-07D5-4AE9-BFBB-9EAF2D861214Q34700316-0C39CE42-AA4B-4302-ADC5-8AD20B9CED8BQ34883750-559F7A0F-8571-42F6-B594-7A19C9815D81Q35360046-93936FC9-9D0F-457C-AE4A-BEB0ECEEB2D3Q35557682-FDA0E8EE-4BF1-4D25-909C-E13371377CBEQ35835741-318249B0-D8F9-45F8-BA9F-BC8F7CD2029EQ35994130-E0F92185-4F24-407E-AA5D-C8DFA7E9FD6AQ35999148-F22CA144-60DD-4063-8F68-7EFE34A161DFQ36160887-BA3361BB-8572-4033-B364-EC67F25A65D1Q36236745-B2C8C951-EDC7-4EFB-B954-F2ECF8A749F3Q36480968-53F3F0E4-1CC2-4272-82FE-719B476252FAQ36741210-9DEAE8A8-BBD0-4D91-8B3D-BB2DFD9FC63FQ37294842-6B2FB7DF-2621-44FE-8C10-CE6A24EF2916Q37358099-28B4074E-D267-48C0-9514-CB0936AC158DQ37616430-5A3C4A33-4648-4B62-8407-7EF9006EFA66Q38088942-399982F2-1410-4847-B179-772C79321D76Q38503363-4A878AE6-4430-4A29-9CC9-B78E4AA9C701Q39197528-81CDA146-1187-4B05-9C05-4F459C3ADB22Q39431367-72579466-8AA3-4098-8465-A9D12BBE1964Q40226972-FEB30076-42C1-4990-8C80-2B8D51799B9DQ42633541-6E235719-5F21-4C67-B363-E626F6F2FC8CQ42638844-A67F7B77-8F3E-4CE4-84AA-237DF25849ADQ42991944-45C1B266-2AB2-430A-A944-3AD54D1A9C75Q45243257-40254317-354C-42E1-A485-EDA4CCB2BB9DQ52839030-C33B6A21-ADCB-40D1-BD60-124B78709495
P2860
Gene expression profiling in the synovium identifies a predictive signature of absence of response to adalimumab therapy in rheumatoid arthritis
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 23 April 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Gene expression profiling in t ...... herapy in rheumatoid arthritis
@en
Gene expression profiling in t ...... erapy in rheumatoid arthritis.
@nl
type
label
Gene expression profiling in t ...... herapy in rheumatoid arthritis
@en
Gene expression profiling in t ...... erapy in rheumatoid arthritis.
@nl
prefLabel
Gene expression profiling in t ...... herapy in rheumatoid arthritis
@en
Gene expression profiling in t ...... erapy in rheumatoid arthritis.
@nl
P2093
P2860
P356
P1476
Gene expression profiling in t ...... herapy in rheumatoid arthritis
@en
P2093
Adrien Nzeusseu Toukap
Anne-Lise Maudoux
Benoît J Van den Eynde
Bernard R Lauwerys
Christine Galant
Frédéric A Houssiau
Ivan Theate
Patrick Durez
Valérie Badot
P2860
P2888
P356
10.1186/AR2678
P577
2009-04-23T00:00:00Z
P5875
P6179
1000953634